Madopar

Medicinal product

(Invented) name

Madopar

Active substance (s)

Levodopa/Benserazidas

Strength

100 mg/25 mg

Pharmaceutical form

pailginto atpalaidavimo kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N04BA02, Levodopa and decarboxylase inhibitor

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-03-26

Date of renewal

Documents

2432_Madopar 100 mg25 mg pailg atp kiet kap_PL_2025-03-26.docx

2432_Madopar 100 mg25 mg pailg atp kiet kap_PZ_2025-03-26.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Kapsulėje yra:	1 vnt.
Levodopa	100 mg
Benserazidas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117045	103146	1103146	buteliukas	N30		Receptinis	LT/L/25/2432/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-03-26	Registruotas